NLRP3 and malignant colon neoplasm: Further, small molecular inhibitors such as andrographolide have been shown to protect against azoxymethane and dextran sodium sulfate-induced colon cancer by inhibiting the NLRP3 inflammasome-mediated inflammatory response [136].